PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 2026American Journal of Perinatology0 citations

Association of Prenatal Counseling of the Mothers of In Utero Opioid Exposed Infants and the Need for Pharmacotherapy in those Infants. A Retrospective Cohort Study

ABAnthony BernickNYNatalie YeaneySBSarah Barsman

Key Points

  • This study examines the impact of virtual prenatal counseling on pharmacotherapy needs for infants exposed to opioids in utero.
  • Retrospective cohort study of mother-infant dyads with gestational age of 35 weeks or more and birth weight ≥ 2 kg.
  • Comparison between mothers who attended prenatal counseling (Group A) and those who did not (Group B).
  • 153 dyads were analyzed, with 80 mothers in Group A and 73 in Group B.
  • The need for pharmacotherapy was 53% lower in Group A (p = 0.044, OR: 0.464, 95% CI: 0.22–0.98).
  • Mothers in Group A were more likely to be enrolled in drug treatment programs and less likely to smoke during pregnancy.
  • Attendance at prenatal counseling was low overall.

Abstract

Abstract A virtual prenatal counseling of mothers whose infants were exposed to opioids was started with the aim of providing an overview of what to expect for the infant after birth and how to reduce the severity of withdrawal. This study aimed to assess the characteristics of mothers who attended this type of visit and received prenatal counseling compared with those who did not. This was a retrospective cohort study of mother–infant dyads with gestational age of 35 weeks or more, with birth weight of≥ 2 kg, and in utero exposure to opioids. Subjects admitted to the neonatal intensive care unit for reasons other than withdrawal and with congenital anomalies were excluded. Subjects were divided into mothers compliant with the virtual prenatal appointment (Group A) and mothers who did not attend their appointment (Group B). Of the 153 dyads included, 80 mothers attended the virtual prenatal appointment, while 73 did not (52%). The need for pharmacotherapy was 53% lower in the compliant Group A (p = 0.044, OR: 0.464, 95% CI: 0.22–0.98), after adjusting for selected covariates. Mothers who attended the appointment were more likely to be in a drug treatment program, less likely to have completed high school, and less likely to smoke during pregnancy. These mothers were more likely to provide mother's own milk (MoM) to their infants. Attendance at prenatal visits was low. Maternal compliance with prenatal visits in opioid exposed infants is associated with a significantly lower need for pharmacotherapy in the infant.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bernick et al. (2026) studied this question.

synapsesocial.com/papers/6a1bd0525783ba022b6fc2d8https://doi.org/10.1055/a-2873-1626
Ask AI
Helpful
Bookmark
Share
View Full Paper